Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Clin Med (Lond). 2015 Dec;15(Suppl 6):s92–s96. doi: 10.7861/clinmedicine.15-6-s92

Table 2.

European guidelines on the spectrum of antifracture efficacy of pharmacological interventions for osteoporosis (*posthoc analysis in a subset of patients).

Intervention Vertebral Non-vertebral Hip
Alendronate + + +
Risedronate + + +
Zoledronic acid + + +
Etidronate + - -
Ibandronate + +* -
Raloxifene + - -
Strontium + + +*
Teriparatide + + -
Denosumab + + +